{"sequenceId":"845366569177","id":"34207245534","language":"English","title":"Analysts Anticipate PetIQ Inc (PETQ) to Post $0.39 EPS","content":"Wall Street analysts forecast that PetIQ Inc (NASDAQ:PETQ) will report $0.39 earnings per share (EPS) for the current quarter, Zacks reports. Five analysts have made estimates for PetIQ’s earnings. The lowest EPS estimate is $0.35 and the highest is $0.44. The business is scheduled to announce its next quarterly earnings results  on Tuesday, August 21st.    According to Zacks, analysts expect that PetIQ will report full-year earnings of $0.81 per share for the current financial year, with EPS estimates ranging from $0.75 to $0.89. For the next fiscal year, analysts anticipate that the firm will post earnings of $1.01 per share, with EPS estimates ranging from $0.91 to $1.17. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover PetIQ.         PetIQ (NASDAQ:PETQ) last issued its quarterly earnings data on Tuesday, May 15th. The company reported $0.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.05 by $0.04. PetIQ had a return on equity of 11.39% and a net margin of 0.17%. The company had revenue of $115.10 million during the quarter, compared to analyst estimates of $108.54 million. The business’s revenue was up 71.8% compared to the same quarter last year.    Several brokerages recently commented on PETQ. BidaskClub raised PetIQ from a “sell” rating to a “hold” rating in a report on Friday, May 25th. Jefferies Group  reiterated a “buy” rating and set a $30.00 target price on shares of PetIQ in a research report on Wednesday, May 16th. Finally, Zacks Investment Research downgraded PetIQ from a “hold” rating to a “sell” rating in a research report on Wednesday, May 16th. One analyst  has rated the stock with a sell rating, one  has given a hold rating and six have assigned  a buy rating to the stock. PetIQ  has an average rating of “Buy” and an average target price of $28.00.  In other news, Director Ronald Kennedy bought 20,200 shares of the firm’s stock in a transaction that occurred on Monday, May 21st. The shares were bought at an average cost of $17.88 per share, for a total transaction of $361,176.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link . Also, CEO Mccord Christensen sold 20,000 shares of the business’s stock in a transaction dated Monday, April 2nd. The stock was sold at an average price of $26.22, for a total value of $524,400.00. The disclosure for this sale can be found here . Insiders sold 65,500 shares of company stock worth $1,657,765 over the last quarter. 45.26% of the stock is owned by company insiders.    A number of hedge funds and other institutional investors have recently modified their holdings of PETQ. Park West Asset Management LLC bought a new stake in  PetIQ during the fourth quarter worth approximately $19,527,000.  Redwood Investments LLC increased its stake in  PetIQ by 55.5% during the first quarter. Redwood Investments LLC now owns 749,611 shares of the company’s stock worth $19,940,000 after acquiring an additional 267,430 shares during the last quarter.  Fiera Capital Corp bought a new stake in  PetIQ during the first quarter worth approximately $6,651,000.  Cooper Creek Partners Management LLC increased its stake in  PetIQ by 192.3% during the fourth quarter. Cooper Creek Partners Management LLC now owns 366,801 shares of the company’s stock worth $8,011,000 after acquiring an additional 241,292 shares during the last quarter.  Finally, BlackRock Inc. increased its stake in  PetIQ by 54.6% during the fourth quarter. BlackRock Inc. now owns 632,556 shares of the company’s stock worth $13,815,000 after acquiring an additional 223,502 shares during the last quarter. 67.00% of the stock is currently owned by institutional investors.    Shares of PETQ traded up $0.43 during trading hours on Friday, hitting $19.58. The stock had a trading volume of 150,556 shares, compared to its average volume of 355,180. The company has a debt-to-equity ratio of 0.69, a current ratio of 2.35 and a quick ratio of 1.09. PetIQ has a 12 month low of $17.03 and a 12 month high of $28.23. The firm has a market capitalization of $473.73 million and a P/E ratio of 50.21.    PetIQ Company Profile    PetIQ, Inc develops, manufactures, and distributes pet medications, and health and wellness products for dogs and cats in the United States, Canada, and Europe. It offers pet prescription medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars; and health and wellness products consisting of specialty treats and other pet products, which include dental treats and nutritional supplements.    Get a free copy of the Zacks research report on PetIQ (PETQ)    For more information about research offerings from Zacks Investment Research, visit Zacks.com","contentWithMarkup":"Wall Street analysts forecast that PetIQ Inc (NASDAQ:PETQ) will report $0.39 earnings per share (EPS) for the current quarter, Zacks reports. Five analysts have made estimates for PetIQ’s earnings. The lowest EPS estimate is $0.35 and the highest is $0.44. The business is scheduled to announce its next quarterly earnings results  on Tuesday, August 21st.    According to Zacks, analysts expect that PetIQ will report full-year earnings of $0.81 per share for the current financial year, with EPS estimates ranging from $0.75 to $0.89. For the next fiscal year, analysts anticipate that the firm will post earnings of $1.01 per share, with EPS estimates ranging from $0.91 to $1.17. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of sell-side research analysts that cover PetIQ.         PetIQ (NASDAQ:PETQ) last issued its quarterly earnings data on Tuesday, May 15th. The company reported $0.09 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.05 by $0.04. PetIQ had a return on equity of 11.39% and a net margin of 0.17%. The company had revenue of $115.10 million during the quarter, compared to analyst estimates of $108.54 million. The business’s revenue was up 71.8% compared to the same quarter last year.    Several brokerages recently commented on PETQ. BidaskClub raised PetIQ from a “sell” rating to a “hold” rating in a report on Friday, May 25th. Jefferies Group  reiterated a “buy” rating and set a $30.00 target price on shares of PetIQ in a research report on Wednesday, May 16th. Finally, Zacks Investment Research downgraded PetIQ from a “hold” rating to a “sell” rating in a research report on Wednesday, May 16th. One analyst  has rated the stock with a sell rating, one  has given a hold rating and six have assigned  a buy rating to the stock. PetIQ  has an average rating of “Buy” and an average target price of $28.00.  In other news, Director Ronald Kennedy bought 20,200 shares of the firm’s stock in a transaction that occurred on Monday, May 21st. The shares were bought at an average cost of $17.88 per share, for a total transaction of $361,176.00. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link . Also, CEO Mccord Christensen sold 20,000 shares of the business’s stock in a transaction dated Monday, April 2nd. The stock was sold at an average price of $26.22, for a total value of $524,400.00. The disclosure for this sale can be found here . Insiders sold 65,500 shares of company stock worth $1,657,765 over the last quarter. 45.26% of the stock is owned by company insiders.    A number of hedge funds and other institutional investors have recently modified their holdings of PETQ. Park West Asset Management LLC bought a new stake in  PetIQ during the fourth quarter worth approximately $19,527,000.  Redwood Investments LLC increased its stake in  PetIQ by 55.5% during the first quarter. Redwood Investments LLC now owns 749,611 shares of the company’s stock worth $19,940,000 after acquiring an additional 267,430 shares during the last quarter.  Fiera Capital Corp bought a new stake in  PetIQ during the first quarter worth approximately $6,651,000.  Cooper Creek Partners Management LLC increased its stake in  PetIQ by 192.3% during the fourth quarter. Cooper Creek Partners Management LLC now owns 366,801 shares of the company’s stock worth $8,011,000 after acquiring an additional 241,292 shares during the last quarter.  Finally, BlackRock Inc. increased its stake in  PetIQ by 54.6% during the fourth quarter. BlackRock Inc. now owns 632,556 shares of the company’s stock worth $13,815,000 after acquiring an additional 223,502 shares during the last quarter. 67.00% of the stock is currently owned by institutional investors.    Shares of PETQ traded up $0.43 during trading hours on Friday, hitting $19.58. The stock had a trading volume of 150,556 shares, compared to its average volume of 355,180. The company has a debt-to-equity ratio of 0.69, a current ratio of 2.35 and a quick ratio of 1.09. PetIQ has a 12 month low of $17.03 and a 12 month high of $28.23. The firm has a market capitalization of $473.73 million and a P/E ratio of 50.21.    PetIQ Company Profile    PetIQ, Inc develops, manufactures, and distributes pet medications, and health and wellness products for dogs and cats in the United States, Canada, and Europe. It offers pet prescription medications, including products for arthritis, thyroid, and diabetes and pain treatments, as well as heartworm preventatives, antibiotics, and other specialty medications; over-the-counter medications and supplies, such as flea and tick control products in various forms comprising spot on treatments, chewables, and collars; and health and wellness products consisting of specialty treats and other pet products, which include dental treats and nutritional supplements.    Get a free copy of the Zacks research report on PetIQ (PETQ)    For more information about research offerings from Zacks Investment Research, visit Zacks.com","tags":[],"publishedDate":"2018-06-02T21:56:36Z","harvestDate":"2018-06-02T21:57:19Z","estimatedPublishedDate":"2018-06-02T21:56:36Z","url":"http://ct.moreover.com/?a=34207245534&p=1u0&v=1&x=yp-AjDwN33RxM97sAsfhEg","originalUrl":"https://www.com-unik.info/2018/06/02/analysts-anticipate-petiq-inc-petq-to-post-0-39-eps.html","outboundUrls":["https://www.americanconsumernews.net/scripts/click.aspx?Zacks=1","http://www.americanconsumernews.net/scripts/click.aspx?Zacks=1","http://www.sec.gov/Archives/edgar/data/1668673/000089924318013755/doc4.xml","http://www.sec.gov/Archives/edgar/data/1668673/000089924318009484/doc4.xml","https://www.marketbeat.com/stocks/NASDAQ/PETQ/","https://www.zacks.com/registration/pfp/?ALERT=zrmodule&ADID=AMERBMN_CONTENT_ZER&skip_rpt_name_check=skip_rpt_name_check&t=PETQ"],"wordCount":"751","dataFormat":"text","duplicateGroupId":"34207245534","media":{"audio":[],"images":[],"video":[],"logo":[]},"publishingPlatform":{},"adultLanguage":"false","topics":[{"name":"Finance latest","group":"Finance"}],"companies":[{"name":"PetIQ Inc","symbol":"PETQ","exchange":"NAS","isin":"US71639T1060","titleCount":1,"contentCount":2,"primary":true},{"name":"PetIQ Inc","symbol":"39L","exchange":"FRA","isin":"US71639T1060","titleCount":1,"contentCount":2,"primary":true},{"name":"PetIQ Inc","symbol":"39L","exchange":"STU","isin":"US71639T1060","titleCount":1,"contentCount":2,"primary":true},{"name":"BlackRock Inc","symbol":"BLQA","exchange":"STU","isin":"US09247X1019","titleCount":0,"contentCount":2,"primary":false},{"name":"BlackRock Inc","symbol":"BLQA","exchange":"MUN","isin":"US09247X1019","titleCount":0,"contentCount":2,"primary":false},{"name":"BlackRock Inc","symbol":"BLK","exchange":"MEX","isin":"US09247X1019","titleCount":0,"contentCount":2,"primary":false},{"name":"BlackRock Inc","symbol":"BLQA","exchange":"FRA","isin":"US09247X1019","titleCount":0,"contentCount":2,"primary":false},{"name":"BlackRock Inc","symbol":"BLQA","exchange":"BER","isin":"US09247X1019","titleCount":0,"contentCount":2,"primary":false},{"name":"BlackRock Inc","symbol":"BLK","exchange":"SWX","isin":"US09247X1019","titleCount":0,"contentCount":2,"primary":false},{"name":"BlackRock Inc","symbol":"BLK","exchange":"NYS","isin":"US09247X1019","titleCount":0,"contentCount":2,"primary":false},{"name":"BlackRock Inc","symbol":"BLAK34","exchange":"BSP","isin":"BRBLAKBDR003","titleCount":0,"contentCount":2,"primary":false},{"name":"BlackRock Inc","symbol":"0QZZ","exchange":"LTS","isin":"US09247X1019","titleCount":0,"contentCount":2,"primary":false},{"name":"BlackRock Inc","symbol":"BLQA","exchange":"ETR","isin":"US09247X1019","titleCount":0,"contentCount":2,"primary":false},{"name":"BlackRock Inc","symbol":"BLK","exchange":"WBO","isin":"US09247X1019","titleCount":0,"contentCount":2,"primary":false},{"name":"Fiera Capital Corp","symbol":"ZFS","exchange":"FRA","isin":"CA31660A1030","titleCount":0,"contentCount":1,"primary":false},{"name":"Fiera Capital Corp","symbol":"FSZ","exchange":"TSE","isin":"CA31660A1030","titleCount":0,"contentCount":1,"primary":false},{"name":"Fiera Capital Corp","symbol":"FRRPF","exchange":"PINX","isin":"CA31660A1030","titleCount":0,"contentCount":1,"primary":false},{"name":"Thomson Reuters Corp","symbol":"TOC","exchange":"FRA","isin":"CA8849031056","titleCount":0,"contentCount":1,"primary":false},{"name":"Thomson Reuters Corp","symbol":"TOC","exchange":"MUN","isin":"CA8849031056","titleCount":0,"contentCount":1,"primary":false},{"name":"Thomson Reuters Corp","symbol":"TRI","exchange":"NYS","isin":"CA8849031056","titleCount":0,"contentCount":1,"primary":false},{"name":"Thomson Reuters Corp","symbol":"TRI","exchange":"TSE","isin":"CA8849031056","titleCount":0,"contentCount":1,"primary":false},{"name":"Thomson Reuters Corp","symbol":"TRI.PR.B","exchange":"TSE","isin":"CA8849033037","titleCount":0,"contentCount":1,"primary":false}],"author":{"name":"Cynthia Vaughn","publishingPlatform":{}},"licenses":[{"name":"Publicly Available"}],"source":{"name":"Community Financial News","homeUrl":"https://www.com-unik.info","category":"Trade","editorialRank":"5","location":{"country":"United States","countryCode":"US","region":"Americas","subregion":"Northern America"},"feed":{"id":"637628019","name":"Community Financial News","mediaType":"News","tags":[],"language":"Unassigned","dataFormat":"text","rank":{"inboundLinkCount":"0"},"inWhiteList":"true","autoTopics":[],"editorialTopics":["Professional","Financials"],"genre":"General"}},"es_id":86994458}